Compare Smith & Nephew plc (SNN) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs 22nd Century Group Inc — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Smith & Nephew plc is far larger — about 8483.2× 22nd Century Group Inc's market cap, and Smith & Nephew plc pays a 2.57% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| SNN | XXII | |
|---|---|---|
Market Cap | $12.64B | $1.49M |
Sector | Health | Technology |
52-Week High | $38.70 | $1.07K |
52-Week Low | $28.73 | $3.90 |
Enterprise Value | $15.41B | -$6.74M |
Dividend Yield | 2.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
